NVS

Novartis
NVS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$243.81B
EV
$270.66B
Shares Outstanding
-
Beta
-

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$113.44
P/E 2025E
13.96x
P/Revenue 2025E
4.47x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Novartis AG

gainify
NVS

Novartis AG

NVS

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic c...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Narasimhan, Vasant

Employees

75,883

IPO Date

1996-11-07

Headquarters

Lichtstrasse 35, Basel, Basel-Stadt, 4056, Switzerland

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.